Our Story

About Consumer Healthcare Products Australia

Consumer Healthcare Products (CHP) Australia is the leading industry voice representing the manufacturers and distributors of consumer healthcare products, including nonprescription medicines. Additionally, we represent businesses that support the consumer healthcare products industry.

9 out of 10 Australians use nonprescription medicines regularly[1], including analgesics, hand sanitisers, cold & flu, nicotine replacement therapies, vitamin and mineral supplements, hay fever and allergy relief, sunscreens and many more.

Available over the counter in pharmacies, supermarkets and convenience stores, nonprescription medicines can assist Australians to maintain productive and healthy lives through:

  • providing symptom relief,
  • aiding health maintenance,
  • supporting the prevention of illness and reducing modifiable risk factors,
  • treating common ailments that don’t require the care of a doctor.

Annually, our industry generates approximately $8 billion in domestic sales, $2 billion in export revenue and employs over 10,000 Australians[2].

With over 14,000 nonprescription products helping keep Australians productive[3], every $1 spent on the most common nonprescription products saves the Australian economy $4[4].

We believe Australians’ health and healthcare system are best served by robust healthcare policies that deliver evidence-based solutions to raise health literacy, promote self-care and self-medication capabilities, and ensure that, where appropriate, more medicines are made available without a prescription.

Our mission is to advance consumer health through responsible self-care.


[1] Consumer Behaviour Factbook (March 2015) Macquarie University

[2] CHP Australia estimates based on:

  • IQVIA & Nielsen Scan Data Sept 2019. Combined Pharmacy & Grocery
  • IBIS Pharmaceutical Product Manufacturing in Australia, March 2019. IBIS World Pty Ltd
  • IBIS Pharmaceutical Wholesaling in Australia, March 2019. IBIS World Pty Ltd

[3] TGA Bilateral Meeting Presentation (December 2019)

[4] The Value of OTC Medicines in Australia (March 2014) Macquarie University – MUCHE Report